Non-invasive ventilation in the treatment of early hypoxemic respiratory failure caused by COVID-19: considering nasal CPAP as the first choice

Guan, Lili; Zhou, Luqian; Grange, Jehane Michael Le; Zheng, Zhong; Chen, Rongchang

doi:10.1186/s13054-020-03054-7

Cited by 22 publications

(21 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…NIV use was limited in the US and Europe owing to concerns over disease transmission and questionable efficacy in ARDS 119120. In China, on the other hand, NIV was used as the initial strategy between 57% and 85% of the time,121122123 and to date no clear evidence shows increased disease transmission to healthcare workers 122124…”

Section: Respiratory Care For Severe Covid-19 Pneumoniamentioning

confidence: 99%

Severe covid-19 pneumonia: pathogenesis and clinical management

Attaway

Scheraga

Bhimraj

et al. 2021

BMJ

310

248

View full text Add to dashboard Cite

Severe covid-19 pneumonia has posed critical challenges for the research and medical communities. Older age, male sex, and comorbidities increase the risk for severe disease. For people hospitalized with covid-19, 15-30% will go on to develop covid-19 associated acute respiratory distress syndrome (CARDS). Autopsy studies of patients who died of severe SARS CoV-2 infection reveal presence of diffuse alveolar damage consistent with ARDS but with a higher thrombus burden in pulmonary capillaries. When used appropriately, high flow nasal cannula (HFNC) may allow CARDS patients to avoid intubation, and does not increase risk for disease transmission. During invasive mechanical ventilation, low tidal volume ventilation and positive end expiratory pressure (PEEP) titration to optimize oxygenation are recommended. Dexamethasone treatment improves mortality for the treatment of severe and critical covid-19, while remdesivir may have modest benefit in time to recovery in patients with severe disease but shows no statistically significant benefit in mortality or other clinical outcomes. Covid-19 survivors, especially patients with ARDS, are at high risk for long term physical and mental impairments, and an interdisciplinary approach is essential for critical illness recovery.

show abstract

Section: Respiratory Care For Severe Covid-19 Pneumoniamentioning

confidence: 99%

Severe covid-19 pneumonia: pathogenesis and clinical management

Attaway

Scheraga

Bhimraj

et al. 2021

BMJ

310

248

View full text Add to dashboard Cite

show abstract

“…Já os autores Guan et al (2020), mostram que o CPAP pode ser considerado como primeira alternativa, ele relata que a pressão positiva continua parece ser mais vantajoso quando aplicado no primeiro momento, mas, em contra partida aumenta os riscos de transmissão, no qual as evidencias ainda são muito controversas no que desrespeita a VMI e a VNI. Segundo Castoñón-Gonzáles et al (2020), a ventilação mecânica simultânea de paciente na terapia intensiva pode ser mais vantajosa, no estudo ele traz até quatro vias simultâneas, mas chega a uma conclusão de que pode ser mais eficaz utilizando em apenas duas na unidade de terapia intensiva, ainda no estudo é evidente que a PEEP programada não demonstra diferença em relação ao pulmão, e ainda é relevante pois leva o dobro de acesso ao dispositivo, mas existe uma complexibilidade durante a monitorização e as conexões entre si.…”

Section: Discussionunclassified

Treatment of patients with acute respiratory insufficiency due to COVID-19: invasive and non-invasive mechanical conditions

Nobre¹,

Silva²,

Pereyra³

2021

JRKS

View full text Add to dashboard Cite

show abstract

“…HFNC respiratory support system allows COVID-19 patients to turn into the prone position three times a day, thus a manoeuvre that helps the patients in improving oxygenation. Non-invasive ventilation (NIV) and high flow nasal oxygen (HFO) breathing assistants have been used to manage acute hypoxemic respiratory failure caused by COVID-19 [ 63 , 64 ].…”

Section: Supportive Wearable Devices For Covid-19 Patientsmentioning

confidence: 99%

Wearable Technology to Assist the Patients Infected with Novel Coronavirus (COVID-19)

et al. 2020

View full text Add to dashboard Cite

Wearable technology plays a significant role in our daily life as well as in the healthcare industry. The recent coronavirus pandemic has taken the world’s healthcare systems by surprise. Although trials of possible vaccines are underway, it would take a long time before the vaccines are permitted for public use. Most of the government efforts are currently geared towards preventing the spread of the coronavirus and predicting probable hot zones. The essential and healthcare workers are the most vulnerable towards coronavirus infections due to their required proximity to potential coronavirus patients. Wearable technology can potentially assist in these regards by providing real-time remote monitoring, symptoms prediction, contact tracing, etc. The goal of this paper is to discuss the different existing wearable monitoring devices (respiration rate, heart rate, temperature, and oxygen saturation) and respiratory support systems (ventilators, CPAP devices, and oxygen therapy) which are frequently used to assist the coronavirus affected people. The devices are described based on the services they provide, their working procedures as well as comparative analysis of their merits and demerits with cost. A comparative discussion with probable future trends is also drawn to select the best technology for COVID-19 infected patients. It is envisaged that wearable technology is only capable of providing initial treatment that can reduce the spread of this pandemic.

show abstract

Non-invasive ventilation in the treatment of early hypoxemic respiratory failure caused by COVID-19: considering nasal CPAP as the first choice

Cited by 22 publications

References 4 publications

Severe covid-19 pneumonia: pathogenesis and clinical management

Severe covid-19 pneumonia: pathogenesis and clinical management

Treatment of patients with acute respiratory insufficiency due to COVID-19: invasive and non-invasive mechanical conditions

Wearable Technology to Assist the Patients Infected with Novel Coronavirus (COVID-19)

Contact Info

Product

Resources

About